FIGS, Inc. 10-Q Summary: Quarter Ended June 30, 2025
Business Context and Reporting Period
This report covers the quarterly period ended June 30, 2025. FIGS, Inc. is a direct-to-consumer healthcare apparel and lifestyle brand, primarily selling scrubwear and non-scrubwear through digital platforms and a growing network of physical "Community Hub" retail stores. The company operates as a single reportable segment.
Key Financial Metrics
| Metric | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net Revenues | $152.6 million | $277.5 million |
| Gross Profit | $102.2 million | $186.7 million |
| Gross Margin | 67.0% | 67.3% |
| Net Income | $7.1 million | $7.0 million |
| Diluted EPS | $0.04 | $0.04 |
| Adjusted EBITDA | $19.7 million | $28.9 million |
| Operating Cash Flow (6mo) | $(3.2) million | |
| Free Cash Flow (6mo) | $(5.6) million | |
| Cash & Equivalents (Balance Sheet) | $50.8 million | |
| Short-term Investments | $188.0 million | |
| Debt | No outstanding borrowings; $95.1 million available under credit facility. |
Material Changes vs. Prior Period
- Revenue Growth: Net revenues increased 5.8% year-over-year (Q2) and 5.3% for the six-month period, driven by higher order volumes and an increase in Average Order Value (AOV) to $117.
- Profitability: Net income surged from $1.1 million to $7.1 million in Q2, with net income margin expanding from 0.8% to 4.7%. Adjusted EBITDA margin improved to 12.9% in Q2.
- Margin Pressure: Gross margin decreased slightly (0.4 percentage points in Q2) due to higher inventory reserves and tariffs, partially offset by duty drawbacks and lower return rates.
- Expense Management: Total operating expenses decreased 3.5% in Q2 compared to the prior year, primarily due to reduced selling and general/administrative expenses.
- Cash Flow: Operating cash flow turned negative at $(3.2) million for the six months ended June 30, 2025, a significant decline from $28.2 million in the prior year period. This was driven by the timing of payments against accrued expenses and higher inventory purchases.
Guidance, Outlook, and Risks
- Trade Policy & Tariffs: The company faces significant cost headwinds from a new 10% universal baseline tariff on U.S. imports and additional country-specific tariffs on Vietnam and Jordan (where production is split evenly). Management is implementing mitigation strategies but expects product costs to rise.
- Supply Chain: Ongoing conflict in the Middle East continues to cause shipping delays and freight cost volatility. The company is adjusting routes and utilizing air freight to mitigate disruptions.
- Capital Allocation: The Board authorized an additional $50 million to the share repurchase program, bringing total authorization to $100 million. Approximately $52 million remains available as of June 30, 2025.
- Executive Compensation: In a subsequent event (July 31, 2025), the Board approved a repricing of options for the CEO and Executive Chair to current fair market value and granted a $6.0 million RSU award to the Executive Chair.
- Tax Legislation: The company is assessing the impact of the "One Big Beautiful Bill Act" (OBBBA) enacted in July 2025, which includes tax cut extensions and international tax framework modifications.
Investor Verification Checklist
- Tariff Impact: Verify the specific financial impact of the 10% baseline tariff and additional Vietnam/Jordan tariffs on future gross margins.
- Cash Flow Reversal: Investigate the drivers behind the shift from positive to negative operating cash flow, specifically regarding inventory build-up and payment timing.
- Inventory Levels: Review the $135.5 million inventory balance and the $3.7 million allowance for excess/obsolete inventory to assess potential future write-downs.
- Executive Retention: Assess the implications of the recent option repricing and new RSU grants on future stock-based compensation expenses.
- Legal Proceedings: Monitor the status of the appealed securities class action dismissal and pending derivative suits.